YDYamo Deniz
Yamo Deniz
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yamo Deniz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Changming Xia
Regeneron Pharmaceuticals Inc. Tarrytown New York USA
1 shared publication - Enrico Heffler
Humanitas University
1 shared publication - Harry J Sacks
Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
1 shared publication - Juby Anne Jacob-Nara
Sanofi
1 shared publication - Megan Hardin
Sanofi, Cambridge, MA, USA
1 shared publication - Nami Pandit-Abid
Sanofi
1 shared publication
Latest Publications
- Open Access
- 1 June 2024
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 17, 551-556
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry
The objective of the RAPID registry is to collect information on use of asthma therapy and the long-term effectiveness and safety of dupilumab for asthma.
- 1 June 2024
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 17, 551-556
Open AccessBaseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry
The objective of the RAPID registry is to collect information on use of asthma therapy and the long-term effectiveness and safety of dupilumab for asthma.